Monday , December 16 2024
Home / Health (page 31)

Health

Glenmark becomes the first company to launch Remogliflozin + Vildagliptin fixed dose combination, at an affordable pricefor adults withType 2 Diabetes in India

Glenmark is the first company in the world to launch Remogliflozin (100 mg) + Vildagliptin (50 mg) Fixed Dose Combination (FDC) The FDC will be marketed under two brand names Remo V and Remozen V Remogliflozin is an innovative, patent-protected sodium glucose co-transporter-2 (SGLT2) inhibitor indicated forthe treatment of Type2 …

Read More »

Another 383 COVID patients recover in Odisha

Bhubaneswar, 30/12/2020 ( Odisha Samachar / Abhishek Mohanty )-  Another 383 Covid patients have recovered and are being discharged on Tuesday. According to the Health and Family Welfare department, 52 recovered cases are from Sundargarh, 36 from Jharsuguda, 35 from Khordha, 32 from Angul, 26 from Cuttack, 25 from Nuapada, …

Read More »

324 COVID patients recover in Odisha

Bhubaneswar, 28/12/2020 ( Odisha Samachar / Abhishek Mohanty )- Another 324 COVID patients have recovered and are being discharged on Monday. According to the Health & Family Welfare department, 34 recovered cases are from Khordha, 31 from Sundargarh, 26 from Baleswar, 25 from Sambalpur, 22 from Mayurbhanj, 22 from Puri, …

Read More »

319 COVID-19 patients recover in Odisha

Bhubaneswar, 27/12/2020 ( Odisha Samachar / Abhishek Mohanty )-Another 319 COVID-19 patients have recovered and are being discharged on Sunday. According to the Health and Family Welfare department, 44 recovered cases are from Khordha, 35 from Baleswar, 35 from Sundargarh, 34 from Angul, 29 from Cuttack, 21 from Sambalpur, 17 …

Read More »

Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris™ Nasal Spray across numerous markets throughout Europe.

The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain. Under the terms of the agreement, Glenmark will be responsible for the development and regulatory approval of Ryaltris™ by relevant European Regulatory Authorities, while Menarini Group will be responsible for the commercialization …

Read More »